WealthTrust Axiom LLC - LA JOLLA PHARMACEUTICAL CO ownership

LA JOLLA PHARMACEUTICAL CO's ticker is LJPC and the CUSIP is 503459604. A total of 45 filers reported holding LA JOLLA PHARMACEUTICAL CO in Q4 2021. The put-call ratio across all filers is 0.54 and the average weighting 2.4%.

Quarter-by-quarter ownership
WealthTrust Axiom LLC ownership history of LA JOLLA PHARMACEUTICAL CO
ValueSharesWeighting
Q2 2022$81,000
-25.0%
25,4000.0%0.03%
-14.7%
Q1 2022$108,000
-8.5%
25,4000.0%0.03%
-10.5%
Q4 2021$118,000
+16.8%
25,4000.0%0.04%
+11.8%
Q3 2021$101,000
-6.5%
25,4000.0%0.03%
-2.9%
Q2 2021$108,000
-15.6%
25,400
-16.4%
0.04%
-18.6%
Q1 2021$128,00030,4000.04%
Other shareholders
LA JOLLA PHARMACEUTICAL CO shareholders Q4 2021
NameSharesValueWeighting ↓
TANG KEVIN C 240,000$1,027,00095.09%
TANG CAPITAL MANAGEMENT LLC 10,049,224$43,011,0008.56%
RTW INVESTMENTS, LP 2,327,903$9,963,0000.15%
Boxer Capital, LLC 890,700$3,812,0000.13%
Tibra Equities Europe Ltd 72,600$311,0000.10%
WealthTrust Axiom LLC 25,400$108,0000.04%
GSA CAPITAL PARTNERS LLP 52,749$226,0000.02%
FIRST MIDWEST BANK TRUST DIVISION 34,231$147,0000.02%
HOLLENCREST CAPITAL MANAGEMENT 42,355$181,0000.02%
Summit Global Investments 48,500$208,0000.01%
View complete list of LA JOLLA PHARMACEUTICAL CO shareholders